In experimental models of MS (i.e., experimental autoimmune encephalomyelitis—EAE), the activation of SIRT1 was shown to reduce neuronal injury in brain, spinal cord, and retinal ganglion cells, preventing subsequent neurological deficit. This evidence concerns the gene SIRT1 and myeloid sarcoma.